AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2016
Aug 15, 2016
30016_dirs_2016-08-15_51aac899-c18d-42a4-b1db-2f1dc2562b74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2016-08-11
Reporting Person: Williams Michael J PhD (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-11 | Common Stock | M | 2576 | $38.7950 | Acquired | 59113 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-11 | Incentive Stock Option (right-to-buy) | $38.7950 | M | 2576 | Disposed | 2018-02-13 | Common Stock (2576) | Direct |
Footnotes
F1: Grant of incentive stock option to buy 1,288 shares of IDEXX Laboratories, Inc. common stock that vested on February 14, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F2: Not applicable.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26